{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Nausea+With+Vomiting+Chemotherapy-Induced&page=2", "query": { "condition": "Nausea With Vomiting Chemotherapy-Induced", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Nausea+With+Vomiting+Chemotherapy-Induced&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-07-24T13:14:29.531Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00086762", "title": "Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Chemotherapy-induced Nausea and Vomiting", "Unspecified Adult Solid Tumor, Protocol Specific", "Breast Cancer", "Gastrointestinal Cancer", "Disease (or Disorder); Gynecological", "Prostate Cancer" ], "interventions": [ { "name": "MR Therapy", "type": "BEHAVIORAL" }, { "name": "Relaxing Music (RM) Therapy", "type": "BEHAVIORAL" }, { "name": "Standard Symptom Management", "type": "BEHAVIORAL" }, { "name": "Questionnaires", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 474, "start_date": "2004-06", "completion_date": "2022-08-11", "has_results": false, "last_update_posted_date": "2022-09-01", "last_synced_at": "2026-07-24T13:14:29.531Z", "location_count": 9, "location_summary": "Wichita, Kansas • Ann Arbor, Michigan • Grand Rapids, Michigan + 6 more", "locations": [ { "city": "Wichita", "state": "Kansas" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Grand Rapids", "state": "Michigan" }, { "city": "Kalamazoo", "state": "Michigan" }, { "city": "Wynnewood", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00086762" }, { "nct_id": "NCT02434861", "title": "An Open Label, Single Dose, Three Part Study to Assess the Effects of Rolapitant (2 mg/mL IV Solution) on the Pharmacokinetics of Digoxin; Sulfasalazine; and the Cooperstown Cocktail (Midazolam, Omeprazole, Warfarin, Caffeine, and Dextromethorphan in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Chemotherapy-induced Nausea and Vomiting" ], "interventions": [ { "name": "Rolapitant", "type": "DRUG" }, { "name": "Digoxin", "type": "DRUG" }, { "name": "Sulfasalazine", "type": "DRUG" }, { "name": "Cooperstown Cocktail", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tesaro, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 102, "start_date": "2015-05", "completion_date": "2015-08", "has_results": false, "last_update_posted_date": "2015-08-25", "last_synced_at": "2026-07-24T13:14:29.531Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02434861" }, { "nct_id": "NCT00065221", "title": "Ginger Control of Chemotherapy Induced Nausea and Vomiting", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Nausea", "Vomiting", "Chemotherapy" ], "interventions": [ { "name": "Ginger", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Center for Complementary and Integrative Health (NCCIH)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 180, "start_date": "2003-06", "completion_date": "2007-01", "has_results": false, "last_update_posted_date": "2008-01-25", "last_synced_at": "2026-07-24T13:14:29.531Z", "location_count": 5, "location_summary": "South Bend, Indiana • Ann Arbor, Michigan • Grand Rapids, Michigan + 1 more", "locations": [ { "city": "South Bend", "state": "Indiana" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Grand Rapids", "state": "Michigan" }, { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00065221" }, { "nct_id": "NCT00511823", "title": "The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Nausea and Vomiting, Chemotherapy-Induced" ], "interventions": [ { "name": "casopitant", "type": "DRUG" }, { "name": "dolasetron", "type": "DRUG" }, { "name": "granisetron", "type": "DRUG" }, { "name": "rosiglitazone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 16, "start_date": "2007-07-23", "completion_date": "2007-09-21", "has_results": false, "last_update_posted_date": "2017-08-03", "last_synced_at": "2026-07-24T13:14:29.531Z", "location_count": 1, "location_summary": "Evansville, Indiana", "locations": [ { "city": "Evansville", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00511823" }, { "nct_id": "NCT07169851", "title": "A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Nausea", "Vomiting", "Drug-Related Side Effects and Adverse Reactions", "Neoplasms" ], "interventions": [ { "name": "LY3537021", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Standard of Care Antiemetic Therapies", "type": "DRUG" }, { "name": "Background Chemotherapy", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 204, "start_date": "2025-11-28", "completion_date": "2027-02", "has_results": false, "last_update_posted_date": "2026-07-20", "last_synced_at": "2026-07-24T13:14:29.531Z", "location_count": 20, "location_summary": "Greenbrae, California • Irvine, California • Los Alamitos, California + 17 more", "locations": [ { "city": "Greenbrae", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "Los Alamitos", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Fort Collins", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT07169851" }, { "nct_id": "NCT06065722", "title": "Prevention of Breakthrough CINV in Patients Receiving Moderately or Highly Emetogenic Chemotherapy", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chemotherapy Induced Nausea and Vomiting" ], "interventions": [ { "name": "Akynzeo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Simon Williamson Clinic", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2023-09-09", "completion_date": "2023-12-31", "has_results": false, "last_update_posted_date": "2023-10-10", "last_synced_at": "2026-07-24T13:14:29.531Z", "location_count": 1, "location_summary": "Mount Olive, Alabama", "locations": [ { "city": "Mount Olive", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT06065722" }, { "nct_id": "NCT00642512", "title": "Dronabinol Versus Standard Ondansetron Antiemetic Therapy in Preventing Delayed-Onset Chemotherapy-Induced Nausea and Vomiting", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chemotherapy Induced Nausea and Vomiting" ], "interventions": [ { "name": "dronabinol", "type": "DRUG" }, { "name": "ondansetron", "type": "DRUG" }, { "name": "dronabinol/ondansetron", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Solvay Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 64, "start_date": "2003-07", "completion_date": "2004-07", "has_results": false, "last_update_posted_date": "2008-04-03", "last_synced_at": "2026-07-24T13:14:29.531Z", "location_count": 43, "location_summary": "Tucson, Arizona • Anaheim, California • Fountain Valley, California + 37 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Greenbrae", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00642512" }, { "nct_id": "NCT01054456", "title": "A Study of Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Participants Who Have Experienced CINV(Chemotherapy-Induced Nausea and Vomiting) During the Previous Cycle of Low Emetogenic Chemotherapy (LEC)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Patients With Confirmed Malignant Disease to Receive Low Emetogenic Chemotherapy (LEC) or Who Experienced at Least Nausea and Vomiting During Last Cycle of LEC" ], "interventions": [ { "name": "palonesetron", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eisai Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 36, "start_date": "2009-10-27", "completion_date": "2010-12-08", "has_results": true, "last_update_posted_date": "2020-12-23", "last_synced_at": "2026-07-24T13:14:29.531Z", "location_count": 9, "location_summary": "Sunrise, Florida • Galesburg, Illinois • Skokie, Illinois + 6 more", "locations": [ { "city": "Sunrise", "state": "Florida" }, { "city": "Galesburg", "state": "Illinois" }, { "city": "Skokie", "state": "Illinois" }, { "city": "Madisonville", "state": "Kentucky" }, { "city": "Nyack", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01054456" }, { "nct_id": "NCT00880191", "title": "Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Nausea and Vomiting", "Unspecified Adult Solid Tumor, Protocol Specific" ], "interventions": [ { "name": "dexamethasone", "type": "DRUG" }, { "name": "gabapentin", "type": "DRUG" }, { "name": "placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Alliance for Clinical Trials in Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 430, "start_date": "2009-04", "completion_date": "2015-05", "has_results": true, "last_update_posted_date": "2016-07-06", "last_synced_at": "2026-07-24T13:14:29.531Z", "location_count": 247, "location_summary": "Scottsdale, Arizona • Aurora, Colorado • Boulder, Colorado + 163 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Boulder", "state": "Colorado" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00880191" }, { "nct_id": "NCT00404378", "title": "Study Of Healthy Subjects To Assess The Effect Of Ketoconazole And The Way The Body Will React To Casopitant [GW679769]", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Nausea and Vomiting, Chemotherapy-Induced" ], "interventions": [ { "name": "ketoconazole", "type": "DRUG" }, { "name": "casopitant 100 mg", "type": "DRUG" }, { "name": "Casopitant 50 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 15, "start_date": "2006-10-20", "completion_date": "2007-01-05", "has_results": false, "last_update_posted_date": "2017-09-12", "last_synced_at": "2026-07-24T13:14:29.531Z", "location_count": 1, "location_summary": "Lenexa, Kansas", "locations": [ { "city": "Lenexa", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00404378" } ] }